Morgan Stanley’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7
| Closed | -$17 | – | 8204 |
|
|
2025
Q2 | $17 | Hold |
7
| – | – | ﹤0.01% | 8006 |
|
|
2025
Q1 | $20 | Hold |
7
| – | – | ﹤0.01% | 7971 |
|
|
2024
Q4 | $22 | Buy |
+7
| New | +$24 | ﹤0.01% | 7851 |
|
|
2024
Q1 | – | Sell |
-24
| Closed | -$90 | – | 7847 |
|
|
2023
Q4 | $90 | Sell |
24
-197
| -89% | -$900 | ﹤0.01% | 7496 |
|
|
2023
Q3 | $1.22K | Hold |
221
| – | – | ﹤0.01% | 7208 |
|
|
2023
Q2 | $2.41K | Hold |
221
| – | – | ﹤0.01% | 7154 |
|
|
2023
Q1 | $2.75K | Sell |
221
-5,416
| -96% | -$71.9K | ﹤0.01% | 7182 |
|
|
2022
Q4 | $56.1K | Buy |
5,637
+4,166
| +283% | +$46.6K | ﹤0.01% | 6242 |
|
|
2022
Q3 | $18K | Buy |
1,471
+1,250
| +566% | +$17.2K | ﹤0.01% | 6830 |
|
|
2022
Q2 | $3K | Buy |
221
+209
| +1,742% | +$3.15K | ﹤0.01% | 7504 |
|
|
2022
Q1 | $0 | Sell |
12
-5,585
| -100% | -$106K | ﹤0.01% | 7986 |
|
|
2021
Q4 | $134K | Buy |
5,597
+5,585
| +46,542% | +$115K | ﹤0.01% | 6272 |
|
|
2021
Q3 | $0 | Sell |
12
-5,292
| -100% | -$104K | ﹤0.01% | 7947 |
|
|
2021
Q2 | $120K | Buy |
+5,304
| New | +$90.7K | ﹤0.01% | 6271 |
|
|
2019
Q4 | – | Sell |
-5
| Closed | – | – | 6667 |
|
|
2019
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 6656 |
|
|
2019
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 6661 |
|
|
2019
Q1 | $0 | Sell |
5
-7
| -58% | -$81 | ﹤0.01% | 6609 |
|
|
2018
Q4 | $0 | Buy |
12
+7
| +140% | +$74 | ﹤0.01% | 6614 |
|
|
2018
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 6725 |
|
|
2018
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 6678 |
|
|
2018
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 6629 |
|
|
2017
Q4 | $0 | Sell |
5
-2
| -29% | -$64 | ﹤0.01% | 6582 |
|
|
2017
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 6545 |
|
|
2017
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 6597 |
|
|
2017
Q1 | $0 | Sell |
7
-193
| -97% | -$27.9K | ﹤0.01% | 6580 |
|
|
2016
Q4 | $16K | Buy |
200
+175
| +700% | +$16.7K | ﹤0.01% | 6051 |
|
|
2016
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 6318 |
|
|
2016
Q2 | $7K | Sell |
25
-68
| -73% | -$21.8K | ﹤0.01% | 6147 |
|
|
2016
Q1 | $30K | Buy |
93
+72
| +343% | +$20.3K | ﹤0.01% | 5790 |
|
|
2015
Q4 | $7K | Buy |
21
+4
| +24% | +$1.66K | ﹤0.01% | 6312 |
|
|
2015
Q3 | $8K | Buy |
17
+2
| +13% | +$1K | ﹤0.01% | 6289 |
|
|
2015
Q2 | $8K | Sell |
15
-31
| -67% | -$21.3K | ﹤0.01% | 6337 |
|
|
2015
Q1 | $50K | Buy |
+46
| New | +$44.5K | ﹤0.01% | 5793 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6581 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6531 |
|
Other funds holding DARE
AE
CPG
VF
Morgan Stanley's DARE Position: Q3 2025 in Review
Morgan Stanley sold out of Dare Bioscience (DARE) in Q3 2025, closing a stake of 7 shares — an estimated $17 sold.
Morgan Stanley first reported a position in DARE in Q1 2015 and held it in 33 quarters. The position peaked at $134K in Q4 2021. 21 funds tracked by Wall St. Rank hold DARE as of Q3 2025.
- Morgan Stanley reported no remaining Dare Bioscience position as of Q3 2025 after selling out during the quarter.
- Morgan Stanley sold 7 Dare Bioscience shares in Q3 2025, an estimated $17.
- Morgan Stanley first reported a position in Dare Bioscience in Q1 2015 and held it in 33 quarters.
- Morgan Stanley's Dare Bioscience position peaked at $134K in Q4 2021.
- 21 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2025.
Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.